Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio Growth (1y) (2012 - 2023)
Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -14.04% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 73.06% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -13.48% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -21.30% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -408.31% |
| Mar 31, 2023 | 239.55% |
| Dec 31, 2022 | 1,996.02% |
| Sep 30, 2022 | -116.05% |
| Jun 30, 2022 | 0.46% |
| Mar 31, 2022 | -53.27% |
| Dec 31, 2021 | -85.43% |
| Sep 30, 2021 | -40.33% |
| Jun 30, 2021 | -20.34% |
| Mar 31, 2021 | -57.01% |
| Dec 31, 2020 | -0.17% |
| Sep 30, 2020 | 31.42% |
| Jun 30, 2020 | -0.91% |
| Mar 31, 2020 | 16.37% |
| Dec 31, 2019 | 54.16% |
| Sep 30, 2019 | -18.10% |
| Jun 30, 2019 | -4.31% |
| Mar 31, 2019 | -90.11% |
| Dec 31, 2018 | -81.05% |
| Sep 30, 2018 | -99.96% |